Universal Vision Biotechnology Future Growth
Future criteria checks 2/6
Universal Vision Biotechnology is forecast to grow earnings and revenue by 10% and 6.9% per annum respectively. EPS is expected to grow by 10% per annum. Return on equity is forecast to be 27.4% in 3 years.
Key information
10.0%
Earnings growth rate
10.0%
EPS growth rate
| Healthcare earnings growth | 18.8% |
| Revenue growth rate | 6.9% |
| Future return on equity | 27.4% |
| Analyst coverage | Low |
| Last updated | 19 Nov 2024 |
Recent future growth updates
Recent updates
Universal Vision Biotechnology (GTSM:3218) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Apr 03
The Case For Universal Vision Biotechnology Co., Ltd. (GTSM:3218): Could It Be A Nice Addition To Your Dividend Portfolio?
Mar 26Universal Vision Biotechnology Co., Ltd. (GTSM:3218) Shares Could Be 39% Below Their Intrinsic Value Estimate
Mar 08The 22% Return On Capital At Universal Vision Biotechnology (GTSM:3218) Got Our Attention
Feb 07Universal Vision Biotechnology Co., Ltd. (GTSM:3218) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Jan 17
Universal Vision Biotechnology (GTSM:3218) Seems To Use Debt Rather Sparingly
Dec 27Estimating The Fair Value Of Universal Vision Biotechnology Co., Ltd. (GTSM:3218)
Dec 06Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 4,865 | N/A | N/A | N/A | 2 |
| 12/31/2025 | 4,568 | 1,210 | N/A | N/A | 3 |
| 12/31/2024 | 4,247 | 1,078 | N/A | N/A | 3 |
| 9/30/2024 | 4,183 | 1,079 | 1,221 | 1,634 | N/A |
| 6/30/2024 | 4,165 | 1,101 | 1,121 | 1,543 | N/A |
| 3/31/2024 | 4,125 | 1,083 | 1,114 | 1,569 | N/A |
| 12/31/2023 | 4,082 | 1,045 | 1,079 | 1,554 | N/A |
| 9/30/2023 | 4,047 | 1,036 | 969 | 1,480 | N/A |
| 6/30/2023 | 3,897 | 976 | 969 | 1,416 | N/A |
| 3/31/2023 | 3,687 | 903 | 886 | 1,348 | N/A |
| 12/31/2022 | 3,494 | 851 | 775 | 1,268 | N/A |
| 9/30/2022 | 3,273 | 791 | 801 | 1,250 | N/A |
| 6/30/2022 | 3,032 | 719 | 824 | 1,300 | N/A |
| 3/31/2022 | 2,857 | 659 | 778 | 1,141 | N/A |
| 12/31/2021 | 2,632 | 595 | 583 | 912 | N/A |
| 9/30/2021 | 2,469 | 538 | 484 | 822 | N/A |
| 6/30/2021 | 2,399 | 556 | 392 | 722 | N/A |
| 3/31/2021 | 2,269 | 543 | 461 | 805 | N/A |
| 12/31/2020 | 2,053 | 483 | 529 | 827 | N/A |
| 9/30/2020 | 1,865 | 422 | 398 | 669 | N/A |
| 6/30/2020 | 1,628 | 322 | 365 | 607 | N/A |
| 3/31/2020 | 1,503 | 281 | 257 | 500 | N/A |
| 12/31/2019 | 1,419 | 238 | 180 | 419 | N/A |
| 9/30/2019 | 1,340 | 226 | 204 | 409 | N/A |
| 6/30/2019 | 1,285 | 214 | 110 | 306 | N/A |
| 3/31/2019 | 1,233 | 188 | 154 | 326 | N/A |
| 12/31/2018 | 1,195 | 161 | 67 | 273 | N/A |
| 9/30/2018 | 1,165 | 144 | 24 | 226 | N/A |
| 6/30/2018 | 1,144 | 146 | N/A | 244 | N/A |
| 3/31/2018 | 1,107 | 130 | N/A | 229 | N/A |
| 12/31/2017 | 1,082 | 120 | N/A | 236 | N/A |
| 9/30/2017 | 1,085 | 131 | N/A | 269 | N/A |
| 6/30/2017 | 1,068 | 102 | N/A | 239 | N/A |
| 3/31/2017 | 1,072 | 96 | N/A | 223 | N/A |
| 12/31/2016 | 1,073 | 92 | N/A | 255 | N/A |
| 9/30/2016 | 1,038 | 62 | N/A | 210 | N/A |
| 6/30/2016 | 1,031 | 75 | N/A | 240 | N/A |
| 3/31/2016 | 1,014 | 69 | N/A | 221 | N/A |
| 12/31/2015 | 1,014 | 81 | N/A | 184 | N/A |
| 9/30/2015 | 1,016 | 89 | N/A | 222 | N/A |
| 6/30/2015 | 1,013 | 92 | N/A | 253 | N/A |
| 3/31/2015 | 1,000 | 93 | N/A | 226 | N/A |
| 12/31/2014 | 988 | 102 | N/A | 222 | N/A |
| 9/30/2014 | 992 | 119 | N/A | 189 | N/A |
| 6/30/2014 | 972 | 118 | N/A | 173 | N/A |
| 3/31/2014 | 945 | 107 | N/A | 229 | N/A |
| 12/31/2013 | 916 | 86 | N/A | 192 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 3218's forecast earnings growth (10% per year) is above the savings rate (1.1%).
Earnings vs Market: 3218's earnings (10% per year) are forecast to grow slower than the TW market (19.4% per year).
High Growth Earnings: 3218's earnings are forecast to grow, but not significantly.
Revenue vs Market: 3218's revenue (6.9% per year) is forecast to grow slower than the TW market (12.5% per year).
High Growth Revenue: 3218's revenue (6.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 3218's Return on Equity is forecast to be high in 3 years time (27.4%)